The Racing Medication and Testing Consortium plans to recommend a model policy on anabolic steroids later this year and also has approved a plan to establish model policies for withdrawal times for therapeutic drugs used in racehorses.
As the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force prepared to release the results of round two of its super-testing program, the University of Florida appropriately kicked off its first Equine Medical Symposium March 14 with discussion on some therapeutic medications.
Therapeutic medications will be the focus of the next round of "Super-Testing," the results of which should be available the first week of December during the University of Arizona Symposium on Racing. More than 500 blind samples remain to be tested for Class 4 medications.
Most Popular Stories
- California Chrome Draws Rail in PA Derby
- Game On Dude, Won Three Big 'Caps, Retired
- Top 3-Year-Old Fillies to Battle in Cotillion
- Ricardo Beats Baze in Champions Challenge
- Top Stallion Street Cry Dead at Age 16
- Brockton Fair Invites Suffolk Downs Horsemen
- Keeneland September continues steady progress
- Kandaly, 1994 Louisiana Derby Winner, Dies
- MGC Offers Help for Displaced Suffolk Workers
- 2013 Breeding Activity Statistics Released